Therapeutic Asset Ratings
368 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Antibody drug conjugate composed of a humanized monoclonal antibody targeting CLDN18.2 and linker-payload MC-VC-PAB-MMAE
Pancreatic Neoplasm
Shanghai Zhongshan Hospital
P2
CC
(46)
Astragalus
Pancreatic Neoplasm
Shenzhen University General Hospital
P2
CC
(46)
bdb001
Pancreatic Neoplasm
Institut Bergonié
P2
CC
(46)
Bemalenograstim Alfa
Pancreatic Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
CC
(46)
Benmelstobart
Pancreatic Neoplasm
RenJi Hospital
P2
CC
(46)
bkt140
Pancreatic Neoplasm
Gulam Manji
P2
CC
(46)
Blex 404
Pancreatic Neoplasm
Rgene Corporation
P2
CC
(46)
BMS 986253
Pancreatic Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P2
CC
(46)
DALPICICLIB ISETIONATE
Pancreatic Cancer
Ruijin Hospital
P2
CC
(46)
dz-002
Pancreatic Neoplasm
Hoag Memorial Hospital Presbyterian
P2
CC
(46)
Entrectinib
Pancreatic Neoplasm
Hoffmann-La Roche
P2
CC
(46)
Fruquintinib
Pancreatic Neoplasm
Fudan University
P2
CC
(46)
GENETICALLY-MODIFIED ONCOLYTIC TYPE 5 ADENOVIRUS WHICH SELECTIVELY REPLICATES IN TUMOR CELLS CONTAINING DYSFUNCTIONAL P53 GENE (H101)
Pancreatic Neoplasm
Fudan University
P2
CC
(46)
Glipizide
Pancreatic Neoplasm
Memorial Sloan Kettering Cancer Center
P2
CC
(46)
Histamine
Pancreatic Neoplasm
Sahlgrenska University Hospital
P2
CC
(46)
Hrs-7058
Pancreatic Neoplasm
Shandong Suncadia Medicine Co., Ltd.
P2
CC
(46)
Iparomlimab
Pancreatic Cancer
Fudan University
P2
CC
(46)
Jab-21822
Pancreatic Neoplasm
Allist Pharmaceuticals, Inc.
P2
CC
(46)
Kras Tcr-Transduced Pbl
Pancreatic Neoplasm
National Cancer Institute (NCI)
P2
CC
(46)
Levoleucovorin
Pancreatic Neoplasm
Hopital Foch
P2
CC
(46)
Lomustine
Pancreatic Neoplasm
Actuate Therapeutics Inc.
P2
CC
(46)
lt-002 (lactobacillus reuteri atg-f4
Pancreatic Neoplasm
Chungnam National University Hospital
P2
CC
(46)
PANTOPRAZOLE
Pancreatic Neoplasm
Washington University School of Medicine
P2
CC
(46)
Pd-L1 T-Hank
Pancreatic Neoplasm
ImmunityBio, Inc.
P2
CC
(46)
PEGFILGRASTIM
Pancreatic Neoplasm
Australasian Gastro-Intestinal Trials Group
P2
CC
(46)
Showing 101 to 125 of 368 assets
Previous
Page 5 of 15
Next
